KLYG Kelyniam Global Inc (PK)

Kelyniam Global, Inc. (PINKSHEETS: KLYG), announces today that the company has signed a letter of intent to acquire 15% of the equity of an MRI facility located in Henderson, Nevada. The MRI facility is expected to become operational by the end of May, 2010, and management believes this new facility will begin generating revenues in the third quarter of 2010.

The transaction is subject to approval by continued due diligence from Kelyniam's management of the new MRI facility, and the negotiation of the final documentation between the two parties. At this time, there can be no assurance this transaction will be completed on a timely basis, if at all.

If the acquisition does occur, it will add steady revenue and income flow into Kelyniam's already growing revenue base.

Pursuant to the terms of the letter of intent, Kelyniam will pay $250,000 ("Purchase Price") for its equity interest in the MRI facility ("Equity Interest"). In order for the Company to complete the Equity Investment, it will need to raise the necessary capital through the sale of Kelyniam's securities, debt, or a combination thereof, of which there can be no assurance. Pursuant to the terms of the letter of intent, the company will be required to pay $250,000 upon the execution of the final purchase agreement. Additionally, Joseph Delligatti, Kelyniam's new President and Chief Executive Officer, and Roger Findlay, one of Kelyniam's directors, both have an equity interest in MSA Imaging, LLC, the manager and majority owner of the MRI facility.

Kelyniam Global, Inc. recently created a new video describing some of the company's new and exciting technology. The video can be watched by going to the company website and selecting the video icon on the left-hand side of the website.

About Kelyniam Global, Incorporated:

Kelyniam Global, Inc. is a balanced vertically-integrated multi-industry holding corporation. The company's divisions and subsidiaries service a vast array of clients across numerous fields and industries encompassing, but not limited to, dental, medical, automotive, aerospace, jewelry, nautical and consumer products. The company specializes in the use of CADCAM technology with recent developments in the production of high precision replication of artificial bone implants for medical applications.

Contact: James Ketner Kelyniam Global, Inc. www.kelyniam.com 1-800-280-8192